You have 9 free searches left this month | for more free features.

antitumor therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor Patients With COVID19 Infection

Recruiting
  • Tumor
  • COVID-19
    • Shenzhen, Guangdong, China
      Seventh Affiliated Hospital, Sun Yat-sen University
    Aug 22, 2023

    Remaxol® in Drug-induced Liver Injuries During Antitumor Therapy

    Recruiting
    • Cancer
    • Drug Induced Liver Injury
    • Krasnoyarsk, Russian Federation
    • +4 more
    Mar 16, 2023

    Cancer Therapy-related Cardiovascular Toxicity Trial in Beijing (Bifidobacterium Bifidum Oral Capsule, Cisplatin, Carboplatin)

    Not yet recruiting
    • Cancer Therapy-related Cardiovascular Toxicity
    • Bifidobacterium Bifidum Oral Capsule
    • +4 more
    • Beijing, China
      Peking University Third Hospital
    Feb 15, 2023

    Lung Cancer, Organoid, NSCLC Trial in Wuxi (Antitumor therapy guided by organoid drug sensitivity test)

    Recruiting
    • Lung Cancer
    • +2 more
    • Antitumor therapy guided by organoid drug sensitivity test
    • Wuxi, Jiangsu, China
      Affiliated Hospital of Jiangnan University
    Feb 2, 2023

    Myocardial Injury and Intestinal Flora Changes Associated With

    Recruiting
    • Cancer Therapy-related Cardiovascular Toxicity
    • Antitumor drugs
    • Beijing, China
      Zhenyu Tian
    Feb 6, 2023

    MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

    Not yet recruiting
    • MSI-H/dMMR Gastroesophageal-junction Cancer
    • MSI-H/dMMR Gastric Cancer
    • (no location specified)
    Oct 30, 2023

    Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

    Recruiting
    • Recurrent Glioblastoma Multiforme
    • SNC-109 CAR-T Cells
    • Beijing, China
      Chinese PLA General Hospital
    May 11, 2023

    Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck

    Terminated
    • Metastatic Head and Neck Squamous Cell Carcinoma
    • +2 more
    • ImmunoPulse
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Sep 1, 2022

    Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • +5 more
    • (no location specified)
    Jun 7, 2023

    Locally Advanced or Metastatic Solid Tumors Trial in China (IN10018+PLD, IN10018+PLD+Toripalimab)

    Active, not recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • Anyang, Henan, China
    • +6 more
    Apr 25, 2023

    Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)

    Not yet recruiting
    • Solid Tumors With HRAS Alterations
    • +4 more
    • (no location specified)
    Aug 30, 2023

    Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

    Not yet recruiting
    • Solid Tumors
    • (no location specified)
    May 17, 2023

    Biliary Tract Cancer Trial in Goyang-si, Seoul (SMT-NK inj.+Pembrolizumab, Pembrolizumab)

    Recruiting
    • Biliary Tract Cancer
    • Goyang-si, Gyeonggi-do, Korea, Republic of
    • +2 more
    Jun 28, 2022

    Metastatic Melanoma Trial in United States (IN10018, Cobimetinib)

    Recruiting
    • Metastatic Melanoma
    • Miami, Florida
    • +4 more
    Mar 29, 2022

    Small Cell Lung Cancer Recurrent Trial in Madrid, Pamplona, Valencia (Debio 0123, Etoposide, Carboplatin)

    Not yet recruiting
    • Small Cell Lung Cancer Recurrent
    • Debio 0123
    • +2 more
    • Madrid, Spain
    • +3 more
    Apr 3, 2023

    Metastatic Castration Resistant Prostate Cancer Trial in United States (LAVA-1207)

    Recruiting
    • Metastatic Castration Resistant Prostate Cancer
    • LAVA-1207
    • Tampa, Florida
    • +3 more
    Nov 18, 2022

    Gastric Cancer Trial in China (IN10018, Docetaxel)

    Completed
    • Gastric Cancer
    • Anyang, Henan, China
    • +7 more
    Nov 15, 2022

    Advanced Solid Tumor Trial in Taoyuan (Neoantigen-expanded cell therapy.)

    Recruiting
    • Advanced Solid Tumor
    • Neoantigen-expanded cell therapy.
    • Taoyuan, Taiwan
      Chang Gung Memorial Hospital, Linkou
    Aug 18, 2021

    Acute Myeloid Leukemia, Multiple Myeloma Trial in Ostrava, Milan, Roma (MLM-CAR44.1 T-cells at day 0 Single intravenous

    Terminated
    • Acute Myeloid Leukemia
    • Multiple Myeloma
    • MLM-CAR44.1 T-cells at day 0 Single intravenous infusion
    • Ostrava, Czech Republic, Czechia
    • +2 more
    Dec 20, 2021

    Breast Cancer, Solid Tumors Trial in Boston, Grand Rapids, Houston (PF-07220060 + PF-07104091 combination dose escalation,

    Recruiting
    • Breast Cancer
    • Solid Tumors
    • PF-07220060 + PF-07104091 combination dose escalation
    • +2 more
    • Grand Rapids, Michigan
    • +1 more
    Jun 28, 2022

    Cancer Trial in Cambridge (AZD6738, Gemcitabine)

    Recruiting
    • Cancer
    • Cambridge, England, United Kingdom
      Cambridge University Hospitals NHS Foundation Trust
    Jun 3, 2021

    NSCLC, Triple Negative Breast Tumors, Squamous Cell Carcinoma of Head and Neck Trial in United States (Pembrolizumab, TAK-676,

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • West Hollywood, California
    • +5 more
    Mar 17, 2022

    Solid Tumor, Adult Trial in United States (JAB-3312, Binimetinib, Pembrolizumab)

    Recruiting
    • Solid Tumor
    • NSCLC
    • Phoenix, Arizona
    • +14 more
    Oct 26, 2022

    Advanced Solid Tumor, NSCLC, CRC Trial in United States (JAB-21822 (KRAS G12C inhibitor), Cetuximab (EGFR inhibitor))

    Recruiting
    • Advanced Solid Tumor
    • +2 more
    • JAB-21822 (KRAS G12C inhibitor)
    • Cetuximab (EGFR inhibitor)
    • Phoenix, Arizona
    • +3 more
    Sep 7, 2021

    Locally Advanced or Metastatic Urothelial Carcinoma Trial in United States (Avelumab, Sacituzumab Govitecan, M6223)

    Recruiting
    • Locally Advanced or Metastatic Urothelial Carcinoma
    • Coeur d'Alene, Idaho
    • +19 more
    Oct 4, 2022